New Products » See More Epigenase Thymine DNA Glycosylase (TDG) Activity/Inhibition Assay Kit (Mar 2011) Microplate-based procedure to measure activity/inhibition levels of TDG. EpiSonic Multi-Functional Bioprocessor 1100 (Mar 2012) Enhanced version of EpiSonic sonication instruments for high throughput DNA and chromatin shearing in a reproducible manner. MethylFlash 5-Formylcytosine (5-fC) DNA Quantification Kit (Mar 2012) 3 hour 45 minute microplate-based procedure to easily quantify levels of 5-formylcytosine (5-fC). ChromaFlash Plant Chromatin Extraction Kit (Feb 2012) Pre-optimized buffers and reagents to isolate high quality chromatin from plants in less than two hours with this simple procedure. EpiQuik Quantitative PCR Fast Kit (Feb 2012) Quick 70 minute procedure for reproducible, quantitative real time analysis of DNA samples. EpiQuik HDAC Assay Kits (Jan 2012) Complete series of histone deacetylase ELISA-based assay kits to quantify all subtypes of HDAC proteins, available for HDACs 1 through 11. MethylFlash Urine 5-Methylcytosine (5-mC) Quantification Kit (Dec 2011) 4-hour colorimetric or fluorometric method to quantify 5-methylcytosine levels in urine. EpiQuik 8-OHdG DNA Damage Quantification Direct Kits (Nov 2011) Study oxidative DNA damage by quantifying 8-hydroxy-2'-deoxyguanosine directly in DNA samples in an ELISA-like manner. Featured Products Measure global DNA methylation. Colorimetrically or fluorometrically quantify methylation without HPLC or mass spec. Fast histone extraction. Pre-optimized, standardized procedure to isolate total core histones in 1 hour, keeping post-translational modifications intact. Compatible with our histone modification kits. Histone modification series. Quantify all histone H3/H4 methylation and acetylation patterns. Bisulfite conversion in a flash. The BisulFlash™ kit allows you to obtain converted eluate from DNA samples in just 30 minutes. Epigenetic Drug Discovery Services » Learn More Enhance your epigenetic-based drug discovery and development without the burden of increased staff and equipment. Choose better epigenetic drug candidates for further development. Determine specificity of the lead candidates against a wide range of epigenetic targets. Validate the lead candidates in a rapid, reliable, and high throughput assay format.